LVAC
Price:
$10.43
Market Cap:
$149.93M
LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.[Read more]
Industry
Shell Companies
IPO Date
2021-12-17
Stock Exchange
NASDAQ
Ticker
LVAC
According to LAVA Medtech Acquisition Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 33.65. This represents a change of -16.84% compared to the average of 40.46 of the last 4 quarters.
The mean historical PE Ratio of LAVA Medtech Acquisition Corp. over the last ten years is 20.20. The current 33.65 PE Ratio has changed 16.56% with respect to the historical average. Over the past ten years (40 quarters), LVAC's PE Ratio was at its highest in in the September 2022 quarter at 78.13. The PE Ratio was at its lowest in in the June 2021 quarter at -35757.81.
Average
20.20
Median
20.20
Minimum
7.88
Maximum
32.52
Discovering the peaks and valleys of LAVA Medtech Acquisition Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 312.69%
Maximum Annual PE Ratio = 32.52
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = 7.88
Year | PE Ratio | Change |
---|---|---|
2022 | 32.52 | 312.69% |
The current PE Ratio of LAVA Medtech Acquisition Corp. (LVAC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.20
5-year avg
20.20
10-year avg
20.20
LAVA Medtech Acquisition Corp.’s PE Ratio is less than Chavant Capital Acquisition Corp. (0), less than Swiftmerge Acquisition Corp. (370.40K), greater than Viscogliosi Brothers Acquisition Corp. (-928.53), greater than Nubia Brand International Corp. (-38.70), less than CF Acquisition Corp. VII (60.44), greater than null (-42.79),
Company | PE Ratio | Market cap |
---|---|---|
0 | $27.52M | |
370.40K | $71.82M | |
-928.53 | $0 | |
-38.70 | $32.30M | |
60.44 | $114.71M | |
-42.79 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Medtech Acquisition Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LAVA Medtech Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is LAVA Medtech Acquisition Corp.'s PE Ratio?
How is the PE Ratio calculated for LAVA Medtech Acquisition Corp. (LVAC)?
What is the highest PE Ratio for LAVA Medtech Acquisition Corp. (LVAC)?
What is the 3-year average PE Ratio for LAVA Medtech Acquisition Corp. (LVAC)?
What is the 5-year average PE Ratio for LAVA Medtech Acquisition Corp. (LVAC)?
How does the current PE Ratio for LAVA Medtech Acquisition Corp. (LVAC) compare to its historical average?